Mackenzie Financial Corp 10x Genomics, Inc. Transaction History
Mackenzie Financial Corp
- $71.1 Billion
- Q4 2024
A detailed history of Mackenzie Financial Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 53,390 shares of TXG stock, worth $441,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,390
Previous 53,390
-0.0%
Holding current value
$441,535
Previous $766,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TXG
# of Institutions
311Shares Held
95.5MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$98.8 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$90.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$52.9 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$47.3 Million0.92% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.36MShares$44.4 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $786M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...